{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:41:53Z","timestamp":1764164513003,"version":"3.46.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Clinical Medicine Talent Training Project funded by Hebei Province","award":["ZF2024183"],"award-info":[{"award-number":["ZF2024183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26272-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:35:49Z","timestamp":1764164149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary exploration of the role of fibrinogen-like protein 2 in neuroblastoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Can","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"26272_CR1","doi-asserted-by":"crossref","unstructured":"Chung C, et al. Neuroblastoma. Pediatr Blood Cancer, (2021), 68 Suppl 2(Suppl 2):e28473.","DOI":"10.1002\/pbc.28473"},{"issue":"2","key":"26272_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.soc.2020.11.010","volume":"30","author":"N Croteau","year":"2021","unstructured":"Croteau, N., Nuchtern, J. & LaQuaglia, M. P. Management of neuroblastoma in Pediatric patients. Surg. Oncol. Clin. N Am 30(2), 291\u2013304 (2021).","journal-title":"Surg. Oncol. Clin. N Am"},{"issue":"8","key":"26272_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","volume":"19","author":"B Qiu","year":"2022","unstructured":"Qiu, B. & Matthay, K. K. Advancing therapy for neuroblastoma. Nat. Rev. Clin. Oncol. 19(8), 515\u2013533 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"26272_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.7150\/ijbs.56748","volume":"17","author":"J Yu","year":"2021","unstructured":"Yu, J. et al. The role of Fibrinogen-like proteins in cancer. Int. J. Biol. Sci. 17(4), 1079\u20131087 (2021).","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"26272_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41467-023-36430-2","volume":"14","author":"Q Zhao","year":"2023","unstructured":"Zhao, Q. et al. FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells. Nat. Commun. 14(1), 735 (2023).","journal-title":"Nat. Commun."},{"issue":"1","key":"26272_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41598-024-51217-1","volume":"14","author":"K Galpin","year":"2024","unstructured":"Galpin, K. et al. FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models. Sci. Rep. 14(1), 787 (2024).","journal-title":"Sci. Rep."},{"issue":"12","key":"26272_CR7","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/cbin.11198","volume":"43","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. MAPK-mediated upregulation of fibrinogen-like protein 2 promotes proliferation, migration, and invasion of colorectal cancer cells. Cell Biol. Int. 43(12), 1483\u20131491 (2019).","journal-title":"Cell Biol. Int."},{"key":"26272_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cytogfr.2022.08.004","volume":"69","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Fibrinogen-like protein 2: Its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors. Cytokine Growth Factor Rev. 69, 73\u201379 (2023).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"26272_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jaci.2022.10.006","volume":"151","author":"E Janssen","year":"2023","unstructured":"Janssen, E. et al. A homozygous truncating mutation of FGL2 is associated with immune dysregulation. J. Allergy Clin. Immunol. 151(2), 572\u2013578 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"26272_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/jcmm.17163","volume":"26","author":"OP Pulkka","year":"2022","unstructured":"Pulkka, O. P. et al. Fibrinogen-like protein 2 in gastrointestinal stromal tumour. J. Cell Mol. Med. 26(4), 1083\u20131094 (2022).","journal-title":"J. Cell Mol. Med."},{"issue":"14","key":"26272_CR11","doi-asserted-by":"publisher","first-page":"1361871","DOI":"10.3389\/fonc.2024.1361871","volume":"7","author":"C Qi","year":"2024","unstructured":"Qi, C. et al. Exploring the role of neutrophil extracellular traps in neuroblastoma: identification of molecular subtypes and prognostic implications. Front Oncol. 7(14), 1361871 (2024).","journal-title":"Front Oncol."},{"issue":"7","key":"26272_CR12","doi-asserted-by":"publisher","first-page":"e002417","DOI":"10.1136\/jitc-2021-002417","volume":"9","author":"R Bao","year":"2021","unstructured":"Bao, R. et al. Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma. J. Immunother Cancer 9(7), e002417 (2021).","journal-title":"J. Immunother Cancer"},{"issue":"1","key":"26272_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-022-02523-x","volume":"41","author":"YL Sha","year":"2022","unstructured":"Sha, Y. L. et al. B3GALT4 remodels the tumor microenvironment through GD2-mediated lipid raft formation and the c-met\/AKT\/mTOR\/IRF-1 axis in neuroblastoma. J. Exp. Clin. Cancer Res. 41(1), 314 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"26272_CR14","doi-asserted-by":"publisher","first-page":"109799","DOI":"10.1016\/j.intimp.2023.109799","volume":"116","author":"L Fu","year":"2023","unstructured":"Fu, L., Liu, Z. & Liu, Y. Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target. Int. Immunopharmacol 116, 109799 (2023).","journal-title":"Int. Immunopharmacol"},{"key":"26272_CR15","doi-asserted-by":"publisher","first-page":"1004700","DOI":"10.3389\/fonc.2022.1004700","volume":"12","author":"X Ma","year":"2022","unstructured":"Ma, X. et al. Targeting FGL2 in glioma immunosuppression and malignant progression. Front Oncol. 12, 1004700 (2022).","journal-title":"Front Oncol."},{"issue":"3","key":"26272_CR16","first-page":"1629","volume":"11","author":"XL Dong","year":"2018","unstructured":"Dong, X. L. et al. Fibrinogen-like protein 2 prothrombinase may contribute to the progression of inflammatory bowel disease by mediating immune coagulation. Int. J. Clin. Exp. Pathol. 11(3), 1629\u20131636 (2018).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"26272_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cca.2020.07.022","volume":"510","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Predictive value of soluble fibrinogen-like protein 2 for survival in traumatic patients with sepsis. Clin. Chim. Acta. 510, 196\u2013202 (2020).","journal-title":"Clin. Chim. Acta."},{"issue":"4","key":"26272_CR18","doi-asserted-by":"publisher","first-page":"e1261","DOI":"10.1002\/brb3.1261","volume":"9","author":"WB Xu","year":"2019","unstructured":"Xu, W. B. et al. Serum soluble fibrinogen-like protein 2 concentration predicts delirium after acute pancreatitis. Brain Behav 9(4), e1261 (2019).","journal-title":"Brain Behav"},{"key":"26272_CR19","doi-asserted-by":"publisher","first-page":"e923531","DOI":"10.12659\/MSM.923531","volume":"26","author":"Y Feng","year":"2020","unstructured":"Feng, Y. et al. Fibrinogen-like protein 2 (FGL2) is a novel biomarker for clinical prediction of human breast cancer. Med Sci Monit 26, e923531 (2020).","journal-title":"Med Sci Monit"},{"issue":"3","key":"26272_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/jnci\/djy107","volume":"111","author":"K Latha","year":"2019","unstructured":"Latha, K. et al. Role of fibrin the Ogen-like protein 2 on immunosuppression and malignant progression in glioma. J. Natl. Cancer Inst. 111(3), 292\u2013300 (2019).","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"26272_CR21","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1002\/jcp.30759","volume":"237","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei, S. et al. NF-\u03baB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J. Cell Physiol. 237(7), 2770\u20132795 (2022).","journal-title":"J. Cell Physiol."},{"issue":"13","key":"26272_CR22","doi-asserted-by":"publisher","first-page":"867516","DOI":"10.3389\/fimmu.2022.867516","volume":"30","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Neutrophil extracellular traps (NETs) promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activate the NF-\u03baB\/NLRP3 inflammasome pathway. Front Immunol. 30(13), 867516 (2022).","journal-title":"Front Immunol."},{"issue":"3","key":"26272_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3892\/ijo.2023.5553","volume":"63","author":"M Wang","year":"2023","unstructured":"Wang, M., Wu, Y., Li, X., Dai, M. & Li, S. IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF \u03baB signaling pathway. Int. J. Oncol. 63(3), 105 (2023).","journal-title":"Int. J. Oncol."},{"issue":"17","key":"26272_CR24","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","volume":"27","author":"M Taki","year":"2021","unstructured":"Taki, M. et al. Tumor immune microenvironment during epithelial-mesenchymal transition. Clin. Cancer Res. 27(17), 4669\u20134679 (2021).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"26272_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial- mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20(2), 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"26272_CR26","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1038\/s41467-025-61088-3","volume":"16","author":"L Cao","year":"2025","unstructured":"Cao, L. et al. Adipocyte-specific Zeb1 downregulation remodels the tumor-associated adipose microenvironment to facilitate female breast cancer progression. Nat. Commun. 16(1), 6011 (2025).","journal-title":"Nat. Commun."},{"issue":"8","key":"26272_CR27","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-12-2432","volume":"73","author":"I Akalay","year":"2013","unstructured":"Akalay, I. et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res. 73(8), 2418\u20132427 (2013).","journal-title":"Cancer Res."},{"issue":"7","key":"26272_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/1878-0261.12093","volume":"11","author":"S Terry","year":"2017","unstructured":"Terry, S. et al. New insights into the role of EMT in tumor immune escape. Mol. Oncol. 11(7), 824\u2013846 (2017).","journal-title":"Mol. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26272-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:35:51Z","timestamp":1764164151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26272-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26272"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26272-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, or publication of this article. This study was based on open-source data and involves no ethical issues or other conflicts of interest. All methods were conducted in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Children\u2019s Hospital of Hebei Province (20210794) and conducted in accordance with the ethical standards of the Declaration of Helsinki. Written informed consent for participation was obtained from the parents or legal guardians of all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"42230"}}